REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
11/24/2025
Back to search
Official data from USPTO
CODEMA PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
40
Latest update
11/25/2025
Trademark type
Combined
Nice classes
35
Filing date
01/18/2018
Registration date
11/24/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/24/2020
Last transaction
11/25/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
3
Owner type
85
Owner location
Bruxelles Belgio, BE
Examiner
MCMORROW,JANICE LEE
Law office
M60
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the term "CODEMA" in light blue in a stylized font above the term "PHARMA" in light blue in a stylized font. An incomplete oval in light blue surrounds "CODEMA" and "PHARMA".
Holders and representatives
Holders
Codema Pharma SA
Representatives
Jeffrey B. Sladkus, Esq. Jeffrey B. Sladkus, Esq.
Technical classification
Nice Classes
Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Commercial evaluation and rating of consumer goods for others prior to purchaseselection and evaluation services of data from manufacturers of pharmaceutical substances and raw materials for the pharmaceutical industryevaluation and rating of pharmaceutical substances and raw materials for the pharmaceutical industry; providing independent ratings and reviews of other businesses for commercial purposesevaluation and rating of manufacturers of pharmaceutical substances and raw materials for the pharmaceutical industry; all the aforesaid services for the purpose of allowing purchasers of pharmaceutical substances and raw materials for the pharmaceutical industry a better selection for purchasing purposes
Publications
History of USPTO decisions and trademark events.
40 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
11/24/2020
ISPO
WITHDRAWN FROM ISSUE - PETITIONS OFFICE REQUEST
09/14/2020
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
09/08/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/08/2020
PUBO
PUBLISHED FOR OPPOSITION
09/08/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/19/2020
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
08/04/2020
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
07/31/2020
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
07/27/2020
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
07/24/2020
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
06/15/2020
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
06/12/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/11/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/10/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/10/2020
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
06/10/2020
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
12/10/2019
GNSI
INQUIRY TO SUSPENSION E-MAILED
12/10/2019
CNSI
SUSPENSION INQUIRY WRITTEN
12/10/2019
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
12/09/2019
ALIE
ASSIGNED TO LIE
11/13/2019
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
05/08/2019
ALIE
ASSIGNED TO LIE
05/08/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/10/2018
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
10/17/2018
GNSL
LETTER OF SUSPENSION E-MAILED
10/17/2018
CNSL
SUSPENSION LETTER WRITTEN
10/17/2018
DOCK
ASSIGNED TO EXAMINER
10/12/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/03/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/03/2018
ALIE
ASSIGNED TO LIE
10/02/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/20/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/03/2018
GNRT
NON-FINAL ACTION E-MAILED
05/03/2018
CNRT
NON-FINAL ACTION WRITTEN
05/03/2018
DOCK
ASSIGNED TO EXAMINER
04/28/2018
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
01/31/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/30/2018
NWAP
NEW APPLICATION ENTERED
01/22/2018
Continuous trademark protection
Get notified about every new filing that threatens CODEMA PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.